Diseases

Cancer Neurological Disorders Infectious Diseases Diabetes Autoimmune Diseases Chronic Diseases Cardiovascular Diseases Infections Kidney Diseases Respiratory Diseases Neurodegenerative Diseases HIV Genetic Disorders Liver Diseases Bacterial Infections Endocrine Disorders ALS Chronic Kidney Disease Viral Infections Bloodborne Diseases Obesity Alzheimer's Disease Heart Disease Genetic Diseases RSV (Respiratory Syncytial Virus) Medical Facilities Vector-Borne Diseases Antimicrobial Resistance Eye Diseases Muscle Diseases Inflammatory Conditions Brain Tumors Plague Neurological Diseases Epilepsy Vascular Diseases Sleep Apnea Endometriosis Neurodegenerative Disorders Victorian Diseases Fungal Infections Tick-Borne Diseases Inflammatory Bowel Disease Respiratory Syncytial Virus (RSV) Blood Disorders Muscular Disorders Age-Related Diseases Foodborne Illnesses Hepatitis C Lymphatic Disorders Urinary Tract Infections Vein Disorders Sexually Transmitted Diseases Lymphatic System Diseases Cardiovascular Disease Inflammatory Diseases Skin Diseases Pulmonary Diseases Tuberculosis

Fugitive Sought by FBI After Alleged GoFundMe Brain‑Cancer Scam

Intensifying an international manhunt, the FBI listing draws new attention to how medical fundraisers can be abused.

Poll Finds Overwhelming Support for Early Alzheimer’s Diagnosis, Access, and the ASAP Act

Large VA Study Links GLP-1 Drugs to Lower Addiction Risk, Fewer Severe Outcomes

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

Colorectal Cancer Now Leads Cancer Deaths Under 50, Prompting a Screening Push

Willie Anderson Says Kidney Transplant Successful After Surgery This Week

FAK Blockade Reprograms Ovarian Tumor Immunity via Omega-3 Signals in Mice

Alpha-Synuclein Tied to Rapid Alzheimer’s Progression in Women, JAMA Study Finds

Study Identifies tRNA‑Modifying Enzymes as Broad Coronavirus Antiviral Targets

Breakthrough T1D Backs CAR-Treg Beta-Cell Therapy as UChicago Reports PD‑L1 mRNA Results

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug